GIS:ETR
गिलियड साइन्सेस
€ १३२.९०
arrow_downward
-१.१९%(-१.६०) 1D
अक्टोबर १३, १७:३५:५४ GMT+२ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GIS...
Open
€ १३४.७०
High
€ १३५.२८
Low
€ १३२.६२
Mkt. cap
१.८३ खरब
Avg. vol.
७७२.००
Volume
४३०.००
52-wk high
€ १३६.२४
52-wk low
€ ९८.९६
No. of employees
१७ हजार
Open
€ १३४.७०
High
€ १३५.२८
Low
€ १३२.६२
Mkt. cap
१.८३ खरब
Avg. vol.
७७२.००
Volume
४३०.००
52-wk high
€ १३६.२४
52-wk low
€ ९८.९६
No. of employees
१७ हजार
News stories
From web sources and news partners
ad-hoc-news.de
·
६ घण्टा पहिले
BofA raises target for Gilead Sciences stock to USD 164.00
MarketBeat
·
७ घण्टा पहिले
Erste Group Bank Comments on Gilead Sciences FY2027 Earnings
ad-hoc-news.de
·
१४ घण्टा पहिले
Gilead Sciences stock loses 0.04 percent pre-market to EUR 134.45
Insider Monkey
·
२० घण्टा पहिले
Biogen (BIIB) vs Amgen (AMGN) and Gilead (GILD): Which Big Pharma Stock is a Better Buy?
Profile
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy.
In 1987, Michael L. Riordan founded the company under the name Oligogen. The original name was a reference to oligonucleotides, small strands of DNA used to target genetic sequences. Gilead held its initial public offering in 1992, and successfully developed drugs including Tamiflu and Vistide that decade.
In the 2000s, Gilead began evolving from a biotechnology company into a large pharmaceutical company, through acquisitions and investments, acquiring several subsidiaries. Gilead is a member of the Nasdaq-100 and the S&P 100.
The company has faced criticism over its business practices, including extremely high pricing of drugs such as Sovaldi and Truvada in the United States relative to production cost and cost in the developing world. Wikipedia
About गिलियड साइन्सेस
CEODaniel O'Day
Employees१७ हजार
Founded१९८७ जुन २२
HeadquartersFoster City, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
Sector-
Websitegilead.com